E-LIB Suche - Ergebnisse für: Burrows, J. F.

1

Evaluation of variable new antigen receptors (vNARs) as a n..:

Smyth, P. ; Ferguson, L. ; Burrows, J. F....
Frontiers in Pharmacology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

2

Combined Plasmapheresis and Complement Inhibition in a High..:

Tardo, D. ; Carlos, L. ; Burrows, F....
Heart, Lung and Circulation. 32 (2023) - p. S147-S148 , 2023

Link: https://doi.org/10.1016/..

3

Octreotide for Gastrointestinal Bleeding in End-Stage Heart..:

Tardo, D. ; Nanayakkara, P. ; Kaur, M....
Heart, Lung and Circulation. 32 (2023) - p. S168 , 2023

Link: https://doi.org/10.1016/..

4

Intensive Tacrolimus Level Monitoring After Itraconazole Pr..:

Song, N. ; Kearney, K. ; Phan, J....
Heart, Lung and Circulation. 32 (2023) - p. S164 , 2023

Link: https://doi.org/10.1016/..

5

HNSCCs overexpressing wild-type HRAS are sensitive to combi..:

Soifer, H. ; Mishra, V. ; Malik, S....
European Journal of Cancer. 174 (2022) - p. S58 , 2022

Link: https://doi.org/10.1016/..

6

Antitumor Activity of Tipifarnib and PI3K Pathway Inhibitor..:

Smith, A. ; Chan, S. ; McCloskey, A....
International Journal of Radiation Oncology*Biology*Physics. 112 (2022) 5 - p. e48 , 2022

Link: https://doi.org/10.1016/..

7

Antitumor activity of tipifarnib and PI3K pathway inhibitor..:

Burrows, F. ; Shivani, M. ; Wang, Z....
European Journal of Cancer. 138 (2020) - p. S43-S44 , 2020

Link: https://doi.org/10.1016/..

8

TIPIFARNIB IN RELAPSED OR REFRACTORY ANGIOIMMUNOBLASTIC T‐C..:

Witzig, T. ; Sokol, L. ; Kim, W....
Hematological Oncology. 37 (2019) S2 - p. 64-65 , 2019

Link: https://doi.org/10.1002/..

9

Sound and light in ICU during different environmental condi..:

Breeding, J. ; Buscher, H. ; Nair, P....
Australian Critical Care. 31 (2018) 2 - p. 135 , 2018

Link: https://doi.org/10.1016/..

10

Recurrent Cytomegalovirus Infections in Heart Transplant Re..:

Offen, S. ; Letchford, D. ; Carlos, L....
Heart, Lung and Circulation. 27 (2018) - p. S125 , 2018

Link: https://doi.org/10.1016/..

11

Preliminary Results From a Phase 2 Trial of Tipifarnib in H..:

Ho, A. ; Chau, N. ; Garcia, I. Brana...
International Journal of Radiation Oncology*Biology*Physics. 100 (2018) 5 - p. 1367 , 2018

Link: https://doi.org/10.1016/..

12

PRELIMINARY RESULTS FROM AN OPEN‐LABEL, PHASE II STUDY OF T..:

Witzig, T. ; Sokol, L. ; Jacobsen, E....
Hematological Oncology. 35 (2017) S2 - p. 251-252 , 2017

Link: https://doi.org/10.1002/..

13

KO-947, a potent and selective ERK inhibitor with slow diss..:

Kessler, L. ; Chen, J. ; Guo, X....
European Journal of Cancer. 69 (2016) - p. S126 , 2016

Link: https://doi.org/10.1016/..

14

Systemic inflammation affects reperfusion following transie..:

Burrows, F. ; Haley, M.J. ; Scott, E....
Experimental Neurology. 277 (2016) - p. 252-260 , 2016

Link: https://doi.org/10.1016/..

15

The Medication Error Minimisation Scheme in a tertiary inte..:

Breeding, J. ; Welch, S. ; Beckett, H....
Australian Critical Care. 28 (2015) 1 - p. 46 , 2015

Link: https://doi.org/10.1016/..